Probiotic to improve iron levels and blood health during pregnancy
Official title: Mechanistic Pathways of Probiotic Supplementation in Optimizing Iron and Hematological Status Among Pregnant Females at Risk of Iron Deficiency Anemia
Run by University of Illinois Chicago · NCT07076849 · Data updated 2026-11-12
This trial will test whether taking the probiotic Lactiplantibacillus plantarum 299v can help pregnant people at risk of iron deficiency improve their iron and blood levels.
Quick facts
| Phase | Phase 2 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years to 45 Years |
| Sex | Women only |
| Enrollment | 250 (estimated) |
| Sponsor | University of Illinois Chicago Academic / other |
| Locations | 1 site (Chicago, Illinois) |
| Status | Recruiting |
| Started | February 1, 2026 |
| Main results expected | October 30, 2030 |
| Study ends | November 30, 2030 |
| Registry record updated | November 2, 2026 |
| Trial ID | NCT07076849 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Pregnant people aged 18–45 with a singleton natural conception at 10–16 weeks gestation who have hemoglobin in the at-risk range (per protocol), can consent in English, and can attend visits at the study site are ideal candidates.
✕Probably not a fit
People with established iron deficiency anemia, other nutritional or hematologic disorders, recent blood transfusion, inflammatory bowel disease, recent antibiotic use, prior bariatric surgery, or other exclusionary conditions are unlikely to benefit from this intervention.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This Phase 2 interventional study enrolls pregnant people at 10–16 weeks gestation who are at risk for iron deficiency based on specific hemoglobin ranges. Participants will take daily capsules of Lactiplantibacillus plantarum 299v or matching placebo and have hematologic and iron markers monitored during pregnancy. The probiotic is hypothesized to enhance non-heme iron absorption by altering gut microbiota, lowering intestinal pH, increasing mucin production, and promoting an anti-inflammatory intestinal environment. Study visits include blood testing and follow-up at the University of Illinois at Chicago to track iron status and safety.
Why it matters
Potential benefit: If successful, the probiotic could reduce the development of iron deficiency in pregnancy and lower the need for oral iron supplements with their gastrointestinal side effects.
How similar studies have gone: Prior small trials and mechanistic studies suggest Lactiplantibacillus plantarum 299v can enhance non-heme iron absorption, but evidence in pregnant populations is limited and not yet definitive.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * singleton naturally conceived pregnancy; * at risk of IDA \[Hb 11.0 - 13.0 g/dL (first trimester) and Hb 10.5 - 12.5 g/dL (second trimester) based on new OB clinical complete blood count (CBC) results obtained from the EHR; * 18 - 45 years old; * 10-22 weeks GA; * fluency in English to provide consent and complete study procedures; * ability to provide consent; Exclusion Criteria: * IDA or other nutritional anemia (i.e., diagnosed or suspected B12 or folate deficiency) based on new OB blood work that includes MCV and MCH to characterize the anemia; * recent blood transfusion; * autoimmune disorder (e.g., rheumatoid arthritis); * inflammatory bowel disease; * oral or IV antibiotic use within 2 months; * previous spontaneous preterm birth; * history of bariatric surgery; * malabsorptive disease; * current hyperemesis; * current eating disorder; * hematologic disorder or trait carrier (e.g., hemochromatosis, β-thalassemia); * current tobacco, alcohol or illicit drug use (Excluding marijuana).
Where it's running
-
University of Illinois at Chicago
Chicago, Illinois, United States Recruiting
Study contacts
- Study coordinator: Mary Dawn Koenig, PhD, RN, CNM
- Email: marydh@uic.edu
- Phone: 312-996-7982
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Pregnant Women Living with HIV on Bictegravir/Emtricitabine/Tenofovir Alafenamide
This study looks at how B/F/TAF is used in pregnant women with HIV and whether it helps maintain viral suppression from before conception through delivery.
-
Pelvic Floor Training and a Modified Lumbopelvic Belt for Symphysis Pubis Pain in Pregnancy
This study tests whether pelvic floor muscle training plus a modified lumbopelvic belt can reduce pain and improve function for pregnant women with symphysis pubis pain.
-
Effective Communication in VBAC Counseling
This study tests how clearly doctors and midwives explain VBAC options during prenatal visits and whether patients feel understood.
-
Innovative Multidisciplinary and Virtual Care for IBD in Pregnancy
This study tests a dedicated IBD pregnancy care model, including a new virtual approach, to see if it improves access and quality of care for pregnant people with Crohn's disease or ulcerative colitis.
-
Compare spinal-epidural versus general anesthesia for babies after cesarean delivery
This trial tests whether the type of anesthesia used for cesarean delivery affects newborn hearing in babies.
-
Pregnant women weight-management support via an app and care model
Aims to try a smartphone-based weight-management program plus professional support for pregnant women to see if it helps manage gestational weight and promote healthy behaviors.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.